COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

Piper Sandler 32nd Annual Healthcare Conference

Nov 23, 2020

Southwest IDEAS Investor Conference

Nov 18, 2020 at 8:00 AM EST

Listen to webcast

November Investor Presentation

Nov 17, 2020

Supporting Materials

View Presentation 1 MB

BDSI Third Quarter 2020 Financial Results Call and Webcast

Nov 5, 2020 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 601.9 KB

Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2020 at 11:20 AM EDT

Listen to webcast

H.C. Wainwright 22nd Annual Global Investor Conference

Sep 14, 2020 at 12:30 PM EDT

Listen to webcast

BDSI Second Quarter 2020 Financial Results Call and Webcast

Aug 5, 2020 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 662.8 KB

William Blair 40th Annual Growth Stock Conference

Jun 11, 2020 at 9:40 AM EDT

Listen to webcast

Jefferies Virtual Healthcare Conference

Jun 2, 2020 at 3:00 PM EDT

Listen to webcast

Supporting Materials

View Presentation 1.3 MB

Recent BDSI News

BioDelivery Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021 February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full ...

BioDelivery Sciences CFO Terry Coelho Promoted to Executive Vice President February 11, 2021

Brings Track Record of Success to Expanded Role RALEIGH, N.C. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer, ...

BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting January 15, 2021

Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA ® to Oxycodone on January 16 from 1:10pm – 2:10pm CT RALEIGH, N.C. , Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now